Doxercalciferol

FDA Approved: * August 30, 2013
Pharm Company: * MYLAN PHARMA
Category: Thyroid

Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease.[1] It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.[2] Docercalciferol is the vitamin D2 analogue of alfacalcidol.[3] It undergoes 25-hydroxylation in the liver to become the active ercalcitriol, without the involvement of kidneys.[4] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Doxercalciferol g
Doxercalciferol 1 ug/1 Oral Capsule, Liquid Filled
NDC: 66993-186
Labeler:
Prasco Laboratories
Doxercalciferol g
Doxercalciferol 2.5 ug/1 Oral Capsule, Liquid Filled
NDC: 66993-187
Labeler:
Prasco Laboratories
Doxercalciferol r
Doxercalciferol .5 ug/1 Oral Capsule
NDC: 68084-872
Labeler:
American Health Packaging
Doxercalciferol r
Doxercalciferol .5 ug/1 Oral Capsule
NDC: 0054-0338
Labeler:
Roxane Laboratories, Inc.
Doxercalciferol g
Doxercalciferol .5 ug/1 Oral Capsule
NDC: 0955-1720
Labeler:
Winthrop U.S.
Doxercalciferol g
Doxercalciferol 1 ug/1 Oral Capsule
NDC: 0955-1721
Labeler:
Winthrop U.S.
Doxercalciferol g
Doxercalciferol 2.5 ug/1 Oral Capsule
NDC: 0955-1722
Labeler:
Winthrop U.S.
Doxercalciferol g
Doxercalciferol .5 ug/1 Oral Capsule
NDC: 64980-228
Labeler:
Rising Pharmaceuticals, Inc.
Doxercalciferol g
Doxercalciferol 1 ug/1 Oral Capsule
NDC: 64980-229
Labeler:
Rising Pharmaceuticals, Inc.
Doxercalciferol g
Doxercalciferol 2.5 ug/1 Oral Capsule
NDC: 64980-230
Labeler:
Rising Pharmaceuticals, Inc.
More Results

Related Brands

Drugs with the same active ingredients